You searched for "blindness"
Edinburgh local plans to run Scottish half marathon for Fight for Sight
A local to Edinburgh and East Lothian who suffers from Stargardts disease will run the Scottish half marathon to fundraise for Fight for Sight.Glaucoma UK and The Royal College of Ophthalmologists announce research award 2024
Glaucoma UK and The Royal College of Ophthalmologists are collaborating to run this prestigious award which has previously funded a range of research topics from prospective stem cell treatments to the use of big data in patient risk stratification.Orbis and FundamentalVR to talk at 100% Optical
The health care technology company teams up with the global non-profit to showcase how simulation, telemedicine and virtual reality (VR) are changing the landscape of cataract surgery education.Moorfields: The 2025 macula course
The 2025 Macula course will take place from 2nd - 5th June 2025. Bookings are now open. Retinal diseases are a major cause of blindness. Diagnostic investigations, understanding of disease mechanisms, new therapies, and the evidence base, have all evolved...
Children with Vision Impairment: Assessment, Development, and Management
Childhood blindness is a major public health concern worldwide with several implications ranging from a child’s development, education, and employment opportunities to social and functional challenges. This book offers a succinct, sequential approach to understanding conditions which lead to visual...Ophthalmology Foundation: a promising new beginning
The world’s leaders in ophthalmology have created the new Ophthalmology Foundation, to make prevention of blindness and maintenance of high quality vision accessible to people of all nations. Board of Directors President David EI Pyott explains their vision for the...
Transfected RPE cells inhibit AMD in rats
Age-related macular degeneration (AMD) is a leading cause of blindness in the elderly. Wet AMD is characterised by choroidal neovascularisation, new vessels into the retina, leading to leakage and tissue damage. Many proangiogenic factors particularly vascular endothelial growth factor (VEGF)...
Outcomes of ‘treat and extend’ for neovascular AMD
The authors report on 24-month outcomes of anti-vascular endothelial growth factor (anti-VEGF) therapy using a ‘treat and extend’ regime for treatment-naïve neovascular age-related macular degeneration (nAMD). Data for this study was collected from the Fight Retinal Blindness observational registry based...
Ovarian hormones drive onset of Sjogren’s disease in mice
Sjogren’s syndrome (SS) is a debilitating, sight-threatening, systemic autoimmune disease with no effective treatment available. SS is characterised by lacrimal gland lymphocytic infiltration and epithelial cell death, as well as by the presence of serum autoantibodies. Patients have severe dry...
Visual prognosis in Irish Leber’s hereditary optic neuropathy
Leber’s hereditary optic neuropathy (LHON) is an inherited optic neuropathy This paper presents a retrospective review of clinical data from patients with LHON presenting to an Irish tertiary referral ophthalmic hospital. Clinical and genetic characteristics were assessed for useful biomarkers...
Effects of ML4 on the eye
Mucolipidosis type IV (ML4) is an autosomal recessive lysosomal storage disease and is caused by variants of the MC0LN1 gene. It often presents in young individuals with eye and ocular adnexa issues. The authors present a case report and literature...
